EUVIMEDEUVIMED entdecken
Crossref

Divergent Roles of C/ EBPβ Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple‐Negative Breast Cancer

Yue Wang, Xinying Wang, Tao Shen, Pei Huang, Ling Gao, Xinhua Liu

The FASEB Journal · 31.08.2025 · 39 (16)

DOI: 10.1096/fj.202501330r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 25.08.2025. Verfasst von Yue Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medicine Sciences, Hangzhou Normal …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, CCAAT-Enhancer-Binding Protein-beta, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C/EBPβ, a member of the CCAAT/enhancer‐binding protein (C/EBP) family of transcription factors, is implicated in monocyte differentiation, inflammation, and cancer progression. However, the distinct roles of its transcriptional activator (LAP) and repressor (LIP) isoforms in triple‐negative breast cancer (TNBC) pathogenesis remain unclear. In this study, we demonstrate that LAP critically promotes TNBC growth, whereas single‐cell RNA sequencing reveals that LAP overexpression drives CD8 + T cell exhaustion, whereas LIP primarily modulates CD4 + T cell function. Integrative ATAC‐seq, ChIP‐seq, and RNA‐seq analyses further show that LAP enhances chromatin accessibility and activates the EGFR signaling pathway, whereas LIP exerts minimal effects on TNBC phenotypes. These findings establish LAP as a key oncogenic driver in TNBC and unveil its immunosuppressive role in shaping the tumor microenvironment, offering potential therapeutic targets for TNBC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsCCAAT-Enhancer-Binding Protein-betaCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHumansFemaleAnimalsMiceProtein IsoformsTumor MicroenvironmentCell Line, TumorDisease ProgressionSignal TransductionGene Expression Regulation, Neoplastic

Substanzen

CCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanProtein Isoforms

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medicine Sciences, Hangzhou Normal University, Zhejiang, Hangzhou, China.

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Zhejiang Provincial Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Wang, X., Shen, T., Huang, P., Gao, L., & Liu, X. (2025). Divergent Roles of C/ EBPβ Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple‐Negative Breast Cancer. The FASEB Journal, 39(16). https://doi.org/10.1096/fj.202501330r

Vancouver

Wang Y, Wang X, Shen T, Huang P, Gao L, Liu X. Divergent Roles of C/ EBPβ Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple‐Negative Breast Cancer. The FASEB Journal. 2025;39(16). doi:10.1096/fj.202501330r

BibTeX
@article{Wang2025,
  author = {Wang, Yue and Wang, Xinying and Shen, Tao and Huang, Pei and Gao, Ling and Liu, Xinhua},
  title = {Divergent Roles of C/ EBPβ Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple‐Negative Breast Cancer},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {16},
  doi = {10.1096/fj.202501330r}
}
Kostenlos starten →